home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Empowering Scientific Breakthroughs: How Scientists Can Use AI and ML for Drug Discovery

 
  September 18, 2024  
     
 
Xtalks, Online
2024-10-29


In the rapidly evolving field of drug discovery, artificial intelligence (AI) and machine learning (ML) have become well-known multipliers in accelerating research and enhancing the development of therapeutic compounds.

This talk will explore Revvity Signals’ strategic journey and share details of existing AI/ML integrations into current Revvity Signals’ software solutions. The team will also discuss the future picture and direction of travel for AI/ML and their software solutions. The speakers will share their future direction and pipeline and explore how these solutions will continue to empower scientists to drive significant breakthroughs in drug discovery.

They will share their insights into the opportunities afforded by AI/ML. Specifically, they will provide examples of how these tools are currently assisting researchers in their daily work in two ways: 1) to help scientists document or efficiently use the software and 2) to help scientists accelerate their science.

They will also discuss about augmented intelligence, where AI and ML tools complement and enhance human expertise rather than replace it. The goal of augmented intelligence is to create solutions that support decision-making processes and accelerate routine tasks, allowing researchers to dedicate more time to higher-level analysis and creative problem-solving.

Register for this webinar today to discover how cutting-edge AI and ML technologies are being leveraged for drug discovery and development.

Keywords: Drug Development, Drug Discovery, CRO, Drug Manufacturing, Medicinal Chemistry, AI, Analytical Chemistry, Data Science, Small Molecule Drug Discovery, Basic Research
 
 
Organized by: Xtalks
Invited Speakers: Zev Wisotsky, Director of Drug Discovery Informatics, Revvity Signals
David Gosalvez, PhD, Executive Director, Strategy & Informatics Portfolio, Revvity Signals
 
Deadline for Abstracts: 2024-10-29
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.